Sera Prognostics

Category Archives

Sera Prognostics Appoints Thomas J. Garite, M.D. as Vice President of Clinical Sciences

SALT LAKE CITY--Sera Prognostics, Inc., The Pregnancy Company™, focused on improving maternal and neonatal health through innovative precision biomarker Read more...

Sera Publishes Data Showing PreTRM Test Can Predict Delivery Prior to 32 Weeks

Jun 04, 2020 | Adam Bonislawski NEW YORK – Sera Prognostics has published new data demonstrating the effectiveness of its PreTRM test for predicting Read more...

Performance of a proteomic preterm delivery predictor in a large independent prospective cohort

Abstract Background Preterm birth remains a common and devastating complication of pregnancy. There remains a need for effective and accurate screening Read more...

Sera Prognostics’ PreTrm Biomarker Test Predicts Adverse Pregnancy Outcomes

New data from the multicenter assessment of a spontaneous preterm birth risk predictor (Treetop), a large, prospective US study, has demonstrated that Read more...

Sera Prognostics appoints Jay M. Moyes as Chief Financial Officer

April 2, 2020 –Salt Lake City Utah –Sera Prognostics, Inc., The Pregnancy Company™, focused on improving maternal and neonatal health through innovative Read more...

SERA PROGNOSTICS TO PRESENT AT THE 40TH ANNUAL COWEN HEALTH CARE CONFERENCE

February 24, 2020 — Sera Prognostics, Inc., the leading health diagnostics company dedicated to improving the lives of women and babies through individualized Read more...

DATA CONFIRMING PERFORMANCE OF SERA PROGNOSTIC’S PRETRM® TEST TO BE PRESENTED AT THE SOCIETY FOR MATERNAL-FETAL MEDICINE’S 40TH ANNUAL PREGNANCY MEETING

SALT LAKE CITY, January 28, 2020 — Sera Prognostics, Inc., the leading women’s precision pregnancy company, today announced two podium presentations Read more...

SERA PROGNOSTICS ANNOUNCES COMPLETION OF IMPORTANT PREVENT PTB CLINICAL INTERVENTION STUDY USING THE PRETRM® TEST

Data quantifying the benefit of Sera’s PreTRM® strategy submitted for scientific review SALT LAKE CITY – January 9, 2020 – Sera Prognostics, Read more...

SERA PROGNOSTICS TO PRESENT AT THE 38TH ANNUAL JP MORGAN HEALTHCARE CONFERENCE

January 6, 2020 — Sera Prognostics, Inc., the leading health diagnostics company dedicated to improving the lives of women and babies through individualized Read more...

New Scientific Publication Shows Sera Prognostics Is Leader in Assessing Preterm Birth Risk

Highlights the Proper Experimental Design and Reporting Required for Accurate Biomarker Prediction Performance Sera Approach Exemplifies Best Practice Read more...

Page 1 of 5123...Last »

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184